Microbiotica: Mike Romanos, Tim Sharpington
Nov 30, 2022
Tim Sharpington has been appointed as CEO of UK microbiome firm Microbiotica, effective Jan. 1, 2023. He will succeed Mike Romanos, who is the founding CEO of the Wellcome Sanger Institute spinout. Sharpington is currently Microbiotica's chief operating officer. He has more than 30 years of experience working in pharma, biotech, and contract research organizations in Europe and the US, including at Vectura, Arakis, ICON, Sequus, and Open Orphan/hVIVO.